Fifth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension
R

Systemic Autoimmune Rheumatic Disease Can Be the Cause of Pulmonary Hypertension in Each WHO Group. How to Recognize and Diagnose a SARD in Your Patient Presenting With PH?

By Fifth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension FEATURING Richard Keating
By Fifth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension FEATURING Richard Keating
144 views
July 14, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
08:01
PERT Consortium 2022

Update on HI-PEITHO - A Landmark Clinical Trial in PE

Feat. K. Rosenfield
21:09
Cleveland Clinic Respiratory Institute

Metabolic Interventions in PAH

Feat. A. R Hemnes
26:02
Mayo Clinic Pulmonary and Critical Care Educational Series

Right Heart Failure Secondary to Non-Group 1 PH

Feat. H. Cajigas
12:18
PERT Consortium 2022

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

Feat. P. Monteleone
13:30
ACC 2023 Conference Coverage

ACC 2023: Clinical Manifestations of Right Ventricular Failure

Feat. J. Huston
17:49
CHEST 2022 Coverage

Perioperative Management of Antithrombotic Therapy

Feat. J. Douketis
09:55
Chao-Wei Hwang

Pericardiocentesis in Pulmonary Hypertension

33:44
Scripps Health

New Therapies for Pulmonary Venous Hypertension: Updates on the Trea…

Feat. R. C. Mohan
22:00
CHEST 2023 Insights

CHEST 2023 Insights: Pulmonary Hypertension Treatment - How to Start…

Feat. J. Elwing
19:04
Vinicio De Jesus Perez

ATS 2022: Addressing Disparities in the Care of Pulmonary Hypertensi…

30:19
UCLA Health

Link Between Parenchymal Lung Disease and PH

Feat. R. Saggar
20:27
University of Colorado Department of Medicine

Hereditary Hemorrhagic Telangiectasia (HHT): An Overview

Feat. P. Hountras
49:54
Temple Lung Center

Pulmonary Arterial Hypertension and Risk Stratification

Feat. S. Sahay
10:07
Inova Cherry Blossom Cardiovascular Symposium 2022

RV Failure and Pulmonary Hypertension

Feat. M. Psotka
14:06
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Understanding Some of the Cellular Mechanisms of Familial PAH

Feat. L. Pandit
36:33
Temple Lung Center

Sotatercept FDA Approval: A New Dawn in PAH Treatment

Feat. A. Raza
08:54
Zeenat Safdar

ATS 2022: Midodrine as a Novel Tool to Optimize Pulmonary Hypertensi…

21:22
Cleveland Clinic Respiratory Institute

Risk Assessment and Treatment Algorithm for PAH

Feat. A. R Cucci
46:27
Sentara's 10th Annual Pulmonary Hypertension Symposium

The Long and Winding Road: The Continuing Mission to Educate Our Reg…

Feat. M. Eggert
35:09
Sentara's 10th Annual Pulmonary Hypertension Symposium

ECHO Evaluation in Pulmonary Hypertension

Feat. E. Sawey